Assessing barriers and facilitators of attitudes toward seasonal influenza vaccination among pregnant women using the Health Belief Model.

IF 3.5 4区 医学 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Human Vaccines & Immunotherapeutics Pub Date : 2025-12-01 Epub Date: 2025-08-12 DOI:10.1080/21645515.2025.2523091
Fang Huang, Jingjing Zhu, Jing Qiu, Juan Li, Yuting Liao, Zhi Li, Zhuoying Huang, Xiang Guo, Xiaodong Sun
{"title":"Assessing barriers and facilitators of attitudes toward seasonal influenza vaccination among pregnant women using the Health Belief Model.","authors":"Fang Huang, Jingjing Zhu, Jing Qiu, Juan Li, Yuting Liao, Zhi Li, Zhuoying Huang, Xiang Guo, Xiaodong Sun","doi":"10.1080/21645515.2025.2523091","DOIUrl":null,"url":null,"abstract":"<p><p>Pregnant women are at elevated risk of severe influenza-related complications and maternal influenza vaccination protects mothers and infants. Nevertheless, the global maternal influenza vaccination rates remain critically low. This cross-sectional survey, conducted in Shanghai during 2023-2024, applied the Health Belief Model (HBM) to evaluate the attitudes and determinants of seasonal influenza vaccination among 3219 pregnant women. Only 10.9% (351/3219) accepted the vaccination, while 89.1% (1851/3219) declined, including 35.4% (1017/3219) who expressed uncertainty. Key facilitators of acceptance included higher education (graduate degree and above: adjusted odds ratio (aOR) = 2.49) and a greater total influenza knowledge score (aOR = 1.07). Strong HBM constructs, including perceived susceptibility (aOR = 1.53), perceived severity (aOR = 1.66), and belief in vaccine benefit (aOR = 2.55) significantly predicted vaccine uptake. The most influential factor was cues to action (aOR = 8.55). Conversely, safety concerns for maternal and fetal health dominated hesitancy, overshadowing other barriers. As the first HBM-based study to assess the attitude to influenza vaccination among pregnant women in China, these findings revealed low baseline awareness and confidence among Shanghai's population of pregnant women. This study highlighted an urgent need to strengthen provider-patient communication to amplify \"cues to action,\" and integrated vaccination advocacy into routine prenatal care. Addressing these barriers could align vaccination rates with global maternal health priorities, leveraging dual protection for mothers and infants.</p>","PeriodicalId":49067,"journal":{"name":"Human Vaccines & Immunotherapeutics","volume":"21 1","pages":"2523091"},"PeriodicalIF":3.5000,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12351702/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Vaccines & Immunotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/21645515.2025.2523091","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/8/12 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Pregnant women are at elevated risk of severe influenza-related complications and maternal influenza vaccination protects mothers and infants. Nevertheless, the global maternal influenza vaccination rates remain critically low. This cross-sectional survey, conducted in Shanghai during 2023-2024, applied the Health Belief Model (HBM) to evaluate the attitudes and determinants of seasonal influenza vaccination among 3219 pregnant women. Only 10.9% (351/3219) accepted the vaccination, while 89.1% (1851/3219) declined, including 35.4% (1017/3219) who expressed uncertainty. Key facilitators of acceptance included higher education (graduate degree and above: adjusted odds ratio (aOR) = 2.49) and a greater total influenza knowledge score (aOR = 1.07). Strong HBM constructs, including perceived susceptibility (aOR = 1.53), perceived severity (aOR = 1.66), and belief in vaccine benefit (aOR = 2.55) significantly predicted vaccine uptake. The most influential factor was cues to action (aOR = 8.55). Conversely, safety concerns for maternal and fetal health dominated hesitancy, overshadowing other barriers. As the first HBM-based study to assess the attitude to influenza vaccination among pregnant women in China, these findings revealed low baseline awareness and confidence among Shanghai's population of pregnant women. This study highlighted an urgent need to strengthen provider-patient communication to amplify "cues to action," and integrated vaccination advocacy into routine prenatal care. Addressing these barriers could align vaccination rates with global maternal health priorities, leveraging dual protection for mothers and infants.

使用健康信念模型评估孕妇对季节性流感疫苗接种态度的障碍和促进因素。
孕妇患严重流感相关并发症的风险较高,孕妇接种流感疫苗可保护母亲和婴儿。然而,全球孕产妇流感疫苗接种率仍然极低。本横断面调查于2023-2024年在上海进行,应用健康信念模型(HBM)评估3219名孕妇对季节性流感疫苗接种的态度和决定因素。只有10.9%(351/3219)的人接受接种,89.1%(1851/3219)的人拒绝接种,其中35.4%(1017/3219)的人表示不确定。接受的主要促进因素包括高等教育(研究生及以上学历:调整优势比(aOR) = 2.49)和更高的流感知识总分(aOR = 1.07)。强HBM结构,包括感知易感性(aOR = 1.53)、感知严重程度(aOR = 1.66)和对疫苗获益的信念(aOR = 2.55)显著预测疫苗摄取。影响最大的因素是行动提示(aOR = 8.55)。相反,对孕产妇和胎儿健康的安全担忧主导了犹豫,掩盖了其他障碍。作为第一项以hbm为基础的研究,评估了中国孕妇对流感疫苗接种的态度,这些研究结果显示上海孕妇人群的基线认知度和信心较低。这项研究强调,迫切需要加强提供者与患者的沟通,以扩大“行动线索”,并将疫苗接种宣传纳入常规产前护理。解决这些障碍可以使疫苗接种率与全球孕产妇保健重点保持一致,利用对母亲和婴儿的双重保护。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics BIOTECHNOLOGY & APPLIED MICROBIOLOGY-IMMUNOLOGY
CiteScore
7.90
自引率
8.30%
发文量
489
审稿时长
3-6 weeks
期刊介绍: (formerly Human Vaccines; issn 1554-8619) Vaccine research and development is extending its reach beyond the prevention of bacterial or viral diseases. There are experimental vaccines for immunotherapeutic purposes and for applications outside of infectious diseases, in diverse fields such as cancer, autoimmunity, allergy, Alzheimer’s and addiction. Many of these vaccines and immunotherapeutics should become available in the next two decades, with consequent benefit for human health. Continued advancement in this field will benefit from a forum that can (A) help to promote interest by keeping investigators updated, and (B) enable an exchange of ideas regarding the latest progress in the many topics pertaining to vaccines and immunotherapeutics. Human Vaccines & Immunotherapeutics provides such a forum. It is published monthly in a format that is accessible to a wide international audience in the academic, industrial and public sectors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信